IMCR - Immunocore EPS beats by $0.21 beats on revenue November, 10 2021 09:02 AM Immunocore Holdings plc Immunocore (NASDAQ:IMCR): Q3 GAAP EPS of -$0.93 beats by $0.21. Revenue of $7.98M(-11% Y/Y) beats by $0.62M. Press Release For further details see: Immunocore EPS beats by $0.21, beats on revenue